ALBUTEROL SULFATE

Post-LOE

albuterol sulfate

ANDAINHALATIONAEROSOL, METERED
Approved
Apr 2020
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
6

Mechanism of Action

CLINICAL PHARMACOLOGY Mechanism of Action In vitro studies and in vivo pharmacologic studies have demonstrated that albuterol has a preferential effect on beta 2 -adrenergic receptors compared with isoproterenol. While it is recognized that beta 2 -adrenergic receptors are the predominant receptors…

Clinical Trials (5)

NCT06664619Phase 3Recruiting

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

Started Dec 2024
724 enrolled
Asthma
NCT06290102Phase 1Completed

Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old

Started May 2024
30 enrolled
Asthma
NCT06245551Phase 3Completed

A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma

Started Dec 2023
64 enrolled
Asthma, Exercise-Induced
NCT06052267Phase 3Recruiting

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Started Aug 2023
2,700 enrolled
Asthma
NCT03371459Phase 2Completed

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Started Dec 2017
46 enrolled
Asthma